What are the major factors driving the growth of the methotrexate drugs market?

In the year 2025, the industry size of methotrexate drugs is estimated at USD 597.64 million. Read More

What would be the CAGR of methotrexate drugs Market over the forecast period?

The methotrexate drugs market size was valued at USD 584.09 million in 2024 and is set to exceed USD 846.99 million by 2037, registering over 2.9% CAGR during the forecast period i.e., between 2025-2037. The surge in the prevalence of rheumatoid arthritis and the increasing prevalence of cancer will drive the market growth.. Read More

Which region will provide more business opportunities for growth of methotrexate drugs market in future?

The major players in the market include Pfizer Inc., Azurity Pharmaceuticals, Inc., Cumberland Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc., Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Sandoz Inc, Hikma Pharmaceuticals PLC, Eisai Co., Ltd. Read More

Methotrexate Drugs Market Share

Global Methotrexate Drug Market TOC

Market Definition
1. Definition
2. Market Segmentation
3. Product Overview
Assumptions and Acronyms
Research Methodology
1. Research Process
2. Primary Research
  1. Manufacturers
  2. Suppliers/Distributors
  3. End-Users
3. Secondary Research
4. Market Size Estimation
Analyst Review
Executive Summary – Global Methotrexate Drug Market
Market Dynamics
1. Growth Drivers
2. Restraints
3. Market Trends
4. Opportunities
Regulatory and Standards Landscape
1. FDA
2. WHO
3. Others
Industry Risk Analysis
World Economic Outlook: Challenges for Global Recovery and its Impact on Global Methotrexate Drug Market
Impact of COVID-19 on the Global Methotrexate Drug Market
Epidemiology Analysis of Cancer and Rheumatoid Arthritis
End-user analysis
Industry Supply Chain Analysis
Competitive Landscape
1. Company Market Share Analysis
2. Company Profiles
  1. Pfizer Inc.
  2. Azurity Pharmaceuticals, Inc.
  3. Cumberland Pharmaceuticals Inc.
  4. Teva Pharmaceuticals USA, Inc.
  5. Amneal Pharmaceuticals LLC
  6. Sun Pharmaceutical Industries Ltd.
  7. Aurobindo Pharma Limited,
  8. Sandoz Inc
  9. Hikma Pharmaceuticals PLC
  10. Eisai Co., Ltd.
  11. Other prominent players
Global Methotrexate Drug Market 2023-2036
1. Market Overview
2. By Value (USD Million)
  1. By Type
    1. >10 mg, 2023-2036F (USD Million)
    2. >15 mg/ml, 2023-2036F (USD Million)
    3. 17.5 mg/ml – 25 mg/ml, 2023-2036F (USD Million)
    4. Others, 2023-2036F (USD Million)
  2. By Disease Type
    1. Cancer, 2023-2036F (USD Million)
      1. Breast Cancer, 2023-2036F (USD Million)
      2. Leukemia, 2023-2036F (USD Million)
      3. Lung Cancer, 2023-2036F (USD Million)
      4. Lymphoma, 2023-2036F (USD Million)
      5. Gestational Trophoblastic Disease, 2023-2036F (USD Million)
      6. Osteosarcoma, 2023-2036F (USD Million)
    2. Autoimmune Diseases, 2023-2036F (USD Million)
      1. Psoriasis, 2023-2036F (USD Million)
      2. Rheumatoid Arthritis, 2023-2036F (USD Million)
      3. Crohn's Disease, 2023-2036F (USD Million)
      4. Others, 2023-2036F (USD Million)
    3. Ectopic Pregnancy, 2023-2036F (USD Million)
    4. Others, 2023-2036F (USD Million)
  3. By Drug Type
    1. Branded, 2023-2036F (USD Million)
    2. Generics, 2023-2036F (USD Million)
  4. By Route Of Administration
    1. Injectable, 2023-2036F (USD Million)
    2. Oral, 2023-2036F (USD Million)
  5. By End User
    1. Hospitals, 2023-2036F (USD Million)
    2. Specialty Clinics, 2023-2036F (USD Million)
    3. Home Healthcare, 2023-2036F (USD Million)
    4. Others, 2023-2036F (USD Million)
  6. By Region
    1. North America, 2023-2036F (USD Million)
    2. Europe, 2023-2036F (USD Million)
    3. Asia Pacific, 2023-2036F (USD Million))
    4. Latin America, 2023-2036F (USD Million)
    5. Middle East & Africa, 2023-2036F (USD Million)
North America Methotrexate Drug Market 2023-2036
1. Market Overview
2. By Value (USD Million)
  1. By Type
    1. >10 mg, 2023-2036F (USD Million)
    2. >15 mg/ml, 2023-2036F (USD Million)
    3. 17.5 mg/ml – 25 mg/ml, 2023-2036F (USD Million)
    4. Others, 2023-2036F (USD Million)
  2. By Disease Type
    1. Cancer, 2023-2036F (USD Million)
      1. Breast Cancer, 2023-2036F (USD Million)
      2. Leukemia, 2023-2036F (USD Million)
      3. Lung Cancer, 2023-2036F (USD Million)
      4. Lymphoma, 2023-2036F (USD Million)
      5. Gestational Trophoblastic Disease, 2023-2036F (USD Million)
      6. Osteosarcoma, 2023-2036F (USD Million)
    2. Autoimmune Diseases, 2023-2036F (USD Million)
      1. Psoriasis, 2023-2036F (USD Million)
      2. Rheumatoid Arthritis, 2023-2036F (USD Million)
      3. Crohn's Disease, 2023-2036F (USD Million)
      4. Others, 2023-2036F (USD Million)
    3. Ectopic Pregnancy, 2023-2036F (USD Million)
    4. Others, 2023-2036F (USD Million)
  3. By Drug Type
    1. Branded, 2023-2036F (USD Million)
    2. Generics, 2023-2036F (USD Million)
  4. By Route Of Administration
    1. Injectable, 2023-2036F (USD Million)
    2. Oral, 2023-2036F (USD Million)
  5. By End User
    1. Hospitals, 2023-2036F (USD Million)
    2. Specialty Clinics, 2023-2036F (USD Million)
    3. Home Healthcare, 2023-2036F (USD Million)
    4. Others, 2023-2036F (USD Million)
  6. By Country
    1. United States, 2023-2036F (USD Million)
    2. Canada, 2023-2036F (USD Million)
Europe Methotrexate Drug Market 2023-2036
1. Market Overview
2. By Value (USD Million)
  1. By Type
  2. By Disease Type
  3. By Drug Type
  4. By Route Of Administration
  5. By End User
  6. By Country
    1. United Kingdom, 2023-2036F (USD Million)
    2. Germany, 2023-2036F (USD Million)
    3. France, 2023-2036F (USD Million)
    4. Italy, 2023-2036F (USD Million)
    5. Spain, 2023-2036F (USD Million)
    6. Russia, 2023-2036F (USD Million)
    7. Netherlands, 2023-2036F (USD Million)
    8. Rest of Europe, 2023-2036F (USD Million)
Asia Pacific Methotrexate Drug Market 2023-2036
1. Market Overview
2. By Value (USD Million)
  1. By Type
  2. By Disease Type
  3. By Drug Type
  4. By Route Of Administration
  5. By End User
  6. By Country
    1. China, 2023-2036F (USD Million)
    2. India, 2023-2036F (USD Million)
    3. Japan, 2023-2036F (USD Million)
    4. South Korea, 2023-2036F (USD Million)
    5. Singapore, 2023-2036F (USD Million)
    6. Australia, 2023-2036F (USD Million)
    7. Rest of Asia Pacific, 2023-2036F (USD Million)
Latin America Methotrexate Drug Market 2023-2036
1. Market Overview
2. By Value (USD Million)
  1. By Type
  2. By Disease Type
  3. By Drug Type
  4. By Route Of Administration
  5. By End User
  6. By Country
    1. Brazil, 2023-2036F (USD Million)
    2. Mexico, 2023-2036F (USD Million)
    3. Argentina, 2023-2036F (USD Million)
    4. Rest of Latin America, 2023-2036F (USD Million)
Middle East & Africa Methotrexate Drug Market 2023-2036
1. Market Overview
2. By Value (USD Million)
  1. By Type
  2. By Disease Type
  3. By Drug Type
  4. By Route Of Administration
  5. By End User
  6. By Country
    1. Israel, 2023-2036F (USD Million)
    2. GCC, 2023-2036F (USD Million)
    3. South Africa, 2023-2036F (USD Million)
    4. Rest of Middle East & Africa, 2023-2036F (USD Million)

Methotrexate Drugs Market Share

North American Market Forecast

The North America methotrexate drugs market is projected to hold a significant market share of 41% by the end of 2037. The demand for methotrexate drugs is propelling in the region due to its high adoption of innovative technologies, and higher healthcare expenditures. In addition, the immediate availability of methotrexate pharmacotherapy, growing research and development linked to methotrexate drugs, multiple cancer survivor campaigns, high rates of psoriasis and arthritis, and the accessibility of reimbursement policies are also expected to contribute to regional growth. Also, the rising number of products and drugs that have been approved by the authorities. For example, U.S. specialty pharmaceutical company Cumberland Pharmaceuticals Inc. announced the launch of her RediTrex injection in November 2020. RediTrex is a new prefilled syringe specifically designed for ease of Use and precise dosing for subcutaneous administration of methotrexate in patients with rheumatoid arthritis and psoriasis.

APAC Market Statistics

The Asia-Pacific methotrexate drugs market is predicted to have notable growth during the forecasted timeframe. The demand for methotrexate drugs in the region is majorly due to the increasing awareness of different medical modalities. Moreover, there are surging number of female populations requiring a medical abortion in the Asia Pacific region.

Methotrexate Drugs Market Share

Methotrexate Drugs Market Share

Browse Key Market Insights with Data Illustration:

Frequently Asked Questions (FAQ)

Subscribe to Our Newsletters

Methotrexate Drugs Market Share

Methotrexate Drugs Market Share

Browse Key Market Insights with Data Illustration:

Frequently Asked Questions (FAQ)

How big is the methotrexate drugs market?

What are the factors driving the methotrexate drugs landscape?

Which region held the largest methotrexate drugs industry share?

Who are the key players in the methotrexate drugs sector?